How Pharma Can Sharpen its Focus on Value-Based Partnerships

Posted by Nitin Jain on Fri, Apr 19, 2019

Ganesh Vedarajan and Joe Stevens co-authored this blog post with Nitin Jain.

Eastman Kodak Co. was in its heyday just a few decades ago before making a fatal flaw: The film manufacturer failed to adapt its business model to the surrounding forces. The company was too focused on manufacturing to see that digital technology was advancing the camera industry by improving the “outcome” for consumers. Pharmaceutical manufacturers face a similar challenge today: The business model is focused on manufacturing drugs, but patients are asking for better outcomes.


>
Read More

‘Beyond the Pill’ Offerings Strike a Chord with IDNs, But Face Regulatory Uncertainty

Posted by Joe Stevens on Fri, Oct 05, 2018

Paul Darling and Matt Ruple co-wrote this blog post with Joe Stevens.

As the shift to value-based care changes how healthcare is delivered in the U.S., provider organizations are realizing that strong internal collaboration helps to ensure that patients receive high-quality, cost-effective care. This trend also creates opportunities for pharma companies to partner with provider organizations to help doctors unlock more value from the medicines that they prescribe and to improve patient care. However, in some cases, pharma companies still struggle to convince providers of the value of “beyond the pill” offerings. And as the state of California’s lawsuit demonstrates, increased regulatory scrutiny presents yet another hurdle for these partnerships.


>
Read More